Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup

Leukemia. 2003 Sep;17(9):1845-50. doi: 10.1038/sj.leu.2403060.

Abstract

Multiple genes have been shown to be independently hypermethylated in lymphoid malignancies. We report here on the extent of concurrent methylation of E-cadherin, Dap-kinase, O(6)MGMT, p73, p16, p15 and p14 in 129 pediatric ALL cases. While most of these genes demonstrated methylation in a proportion of cases, O(6)MGMT, p16 and p14 were infrequently methylated (11, 7 and 3%, respectively). Methylation of at least one gene was found in the vast majority (83%) of cases. To determine the extent and concordance of methylation we calculated a methylation index (MI=number of methylated genes/number of studied genes) for each sample. The average MI was 0.28, corresponding to 2/7 methylated genes. MI was correlated with standard prognostic factors, including immunophenotype, age, sex, WBC and presence of specific translocations (TEL-AML1, BCR-ABL, E2A-PBX1 or MLL-AF4). We determined that children >/=10 years old and children presenting with high WBC (>/=50 x 10(9)/l) both associated with a higher MI (P<0.01 and <0.05, respectively). T-ALLs demonstrated a lower MI (median=0.17) than precursor B ALLs (median=0.28). Among the different molecular subgroups, MLL-ALLs had the highest MI (mean=0.35), while ALLs carrying the t(1;19) had the lowest MI (mean=0.07). The most common epigenetic lesion in childhood ALL was methylation of E-cadherin (72%) independent of the molecular subtype or other clinicopathological factors.

MeSH terms

  • Adolescent
  • Apoptosis Regulatory Proteins
  • Cadherins / genetics
  • Calcium-Calmodulin-Dependent Protein Kinases / genetics
  • Cell Cycle Proteins*
  • Child
  • Child, Preschool
  • Core Binding Factor Alpha 2 Subunit
  • CpG Islands
  • Cyclin-Dependent Kinase Inhibitor p15
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics
  • DNA Methylation*
  • DNA Primers / chemistry
  • DNA Repair
  • DNA, Neoplasm / genetics*
  • DNA-Binding Proteins / genetics
  • Death-Associated Protein Kinases
  • Female
  • Genes, Tumor Suppressor
  • Genes, p53 / genetics
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / metabolism
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Nuclear Proteins / genetics*
  • O(6)-Methylguanine-DNA Methyltransferase / genetics
  • Oncogene Proteins, Fusion / genetics
  • Oncogene Proteins, Fusion / metabolism
  • Phenotype
  • Polymerase Chain Reaction
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • RNA, Neoplasm / genetics
  • Transcription Factors / genetics
  • Translocation, Genetic
  • Tumor Protein p73
  • Tumor Suppressor Protein p14ARF / genetics
  • Tumor Suppressor Proteins*

Substances

  • Apoptosis Regulatory Proteins
  • CDKN2B protein, human
  • Cadherins
  • Cell Cycle Proteins
  • Core Binding Factor Alpha 2 Subunit
  • Cyclin-Dependent Kinase Inhibitor p15
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA Primers
  • DNA, Neoplasm
  • DNA-Binding Proteins
  • Homeodomain Proteins
  • Nuclear Proteins
  • Oncogene Proteins, Fusion
  • RNA, Neoplasm
  • TEL-AML1 fusion protein
  • TP73 protein, human
  • Transcription Factors
  • Tumor Protein p73
  • Tumor Suppressor Protein p14ARF
  • Tumor Suppressor Proteins
  • E2A-Pbx1 fusion protein
  • O(6)-Methylguanine-DNA Methyltransferase
  • Death-Associated Protein Kinases
  • Calcium-Calmodulin-Dependent Protein Kinases